Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly FCF Margin of 2.6% for Q2 2026, up 15638.0% year-over-year from N/an in Q2 2025, and up 90.42% quarter-over-quarter from 27.13% in Q1 2026.
Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported FCF Margin for 4 consecutive years, with 2.6% the latest figure, recorded in Q2 2026.
- In Q2 2026, FCF Margin rose 15638.0% year-over-year to 2.6%; the TTM figure through Jun 2026 stood at 15.84% (up 22517.0% YoY), while the FY2025 annual figure was 95.94%, up 38713.0% from the prior year.
- FCF Margin grew to 2.6% in Q2 2026 per PHAT's latest filing, from 27.13% in the prior quarter.
- Across five years, FCF Margin topped out at 2.6% in Q2 2026 and bottomed at 6155.57% in Q4 2023.
- Historically, FCF Margin has averaged 1078.41% across 4 years, with a median of 213.93% in 2024.
- Annual changes were most pronounced in 2024 — FCF Margin soared 594164 bps — and 2026, when it surged 15638 bps.
- Phathom Pharmaceuticals' FCF Margin stood at 6155.57% in 2023, then jumped by 97 bps to 213.93% in 2024, then jumped by 95 bps to 10.56% in 2025, then jumped by 75 bps to 2.6% in 2026.
- Business Quant data shows PHAT's FCF Margin at 2.6% in Q2 2026, 27.13% in Q1 2026, and 10.56% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | -2.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.60% |
| Mar 31, 2026 | -26.94% |
| Dec 31, 2025 | -10.72% |
| Sep 30, 2025 | -28.38% |
| Jun 30, 2025 | -159.09% |
| Mar 31, 2025 | -297.80% |
| Dec 31, 2024 | -213.50% |
| Sep 30, 2024 | -389.51% |
| Jun 30, 2024 | -965.20% |
| Mar 31, 2024 | -3,611.92% |
| Dec 31, 2023 | -6,120.38% |